Evidence map›Paper›PMID 42762357›Full record

ArticleCancer chemotherapy and pharmacology2026

Correction: Evaluation of QTc interval prolongation in patients with advanced clear cell renal cell carcinoma treated with first line sunitinib.

Agata Sałek-Zań, Mirosława Püsküllüoğlu, Agnieszka Stąpór, Justyna Jaworska, Agnieszka Pietruszka, Aleksandra Grela-Wojewoda, Maciej Stąpór, Tomasz Banaś

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer chemotherapy and pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Agata Sałek-ZańDepartment of Clinical Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, Kraków, 31-115, Poland. agata.salek@krakow.nio.gov.pl.
Mirosława PüsküllüoğluDepartment of Clinical Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, Kraków, 31-115, Poland.
Agnieszka StąpórDepartment of Clinical Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, Kraków, 31-115, Poland.
Justyna JaworskaDepartment of Clinical Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, Kraków, 31-115, Poland.
Agnieszka PietruszkaDepartment of Clinical Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, Kraków, 31-115, Poland.
Aleksandra Grela-WojewodaDepartment of Clinical Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Garncarska 11, Kraków, 31-115, Poland.
Maciej StąpórFaculty of Medicine, Institute of Cardiology, Department of Interventional Cardiology, Jagiellonian University Medical College, St. John Paul II Hospital, Kraków, Poland.
Tomasz BanaśDepartment of Radiation Oncology, Kraków Branch, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42762357
PMCPMC13589698

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.